Trial · NCT07877935
Testing Interventions to Mitigate the Health Impact of Heatwaves on Primary School Children in Climate-vulnerable Districts of Bangladesh.
NCT07877935, Not applicable, Recruiting, BRAC University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Testing Interventions to Mitigate the Health Impact of Heatwaves on Primary School Children in Climate-vulnerable Districts of Bangladesh. Trials, record NCT07877935. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07877935
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Testing Interventions to Mitigate the Health Impact of Heatwaves on Primary School Children in Climate-vulnerable Districts of Bangladesh.
- NCT number
- NCT07877935
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 2,875 participants, estimated
- Lead sponsor
- BRAC University
- Conditions
- Heat Cramps, Heat Rash, Heat Exhaustion, Heat Stress, Heat Anxiety
- Interventions
- Solar reflective paint, Bamboo ceiling with polyethylene foam, Heat education toolkit
- First posted
- 2026-10-16
- Last updated
- 2026-10-16
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Incidence of Heat Rash | April to November each year during 2025-2027 | * Case Definition: Inflammatory skin condition caused by blocked sweat glands, commonly occurring in hot and humid conditions. * Diagnostic Criteria: * Red, itchy rash or tiny blisters on chest, back, neck, or other covered areas * Occurs after sweating or prolonged heat exposure * May be described by the child as prickly, itchy, or burning * Outcome Threshold: Presence of a red, itchy rash or blisters in covered areas following heat exposure, as reported by the child or caregiver or observed directly. |
| Primary | Incidence of Heat Cramps | April to November each year during 2025-2027 | * Case Definition: Painful, involuntary muscle spasms caused by salt loss through sweating, typically after physical activity. * Diagnostic Criteria: * Complaints of muscle cramps or spasms in legs, arms, or abdomen * Occurs after physical exertion in a hot environment * Often accompanied by heavy sweating * Outcome Threshold: Reported or observed muscle pain or spasms following activity in hot conditions, in the absence of severe systemic symptoms. |
| Primary | Incidence of Heat Exhaustion | April to November each year during 2025-2027 | * Case Definition: Heat-related illness resulting from water or salt depletion, leading to fatigue and inability to continue activity, without altered mental status. * Diagnostic Criteria: * At least two of the following symptoms: * Weakness or fatigue * Headache * Nausea or vomiting * Dizziness * Muscle cramps * Heavy sweating * No confusion, disorientation, or unconsciousness * Body temperature less than 40°C * Outcome Threshold: Two or more qualifying symptoms after heat exposure, with normal mental status and no high fever (≥40°C), as reported or observed. |
| Primary | Incidence of Heat stress | April to November each year during 2025-2027 | |
| Primary | Incidence of Heat Anxiety | April to November each year during 2025-2027 | |
| Secondary | Academic performance | April to January each year during 2025-2028 | |
| Secondary | School absenteeism | April to January each year during 2025-2028 | |
| Secondary | Cases of pneumonia | April to November each year during 2025-2027 | |
| Secondary | Cases of diarrhoea | April to November each year during 2025-2027 |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07877935
GET https://conductscience.org/api/trials/v1/NCT07877935/registered